Nantahala Capital Management LLC Cuts Stake in InspireMD, Inc. (NYSE:NSPR)

Nantahala Capital Management LLC lowered its holdings in InspireMD, Inc. (NYSE:NSPR - Free Report) by 24.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,674,565 shares of the company's stock after selling 535,028 shares during the quarter. Nantahala Capital Management LLC owned approximately 6.42% of InspireMD worth $4,404,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of NSPR. Affiance Financial LLC boosted its position in InspireMD by 2.9% during the fourth quarter. Affiance Financial LLC now owns 189,122 shares of the company's stock valued at $497,000 after purchasing an additional 5,376 shares in the last quarter. Legato Capital Management LLC bought a new stake in shares of InspireMD in the 4th quarter valued at about $47,000. Essex Investment Management Co. LLC bought a new position in shares of InspireMD during the 4th quarter worth approximately $191,000. Renaissance Technologies LLC acquired a new stake in InspireMD in the fourth quarter valued at approximately $27,000. Finally, Northern Trust Corp grew its holdings in InspireMD by 103.7% in the fourth quarter. Northern Trust Corp now owns 48,022 shares of the company's stock worth $126,000 after purchasing an additional 24,452 shares during the last quarter. Hedge funds and other institutional investors own 44.78% of the company's stock.

InspireMD Trading Up 3.8 %

Shares of NYSE NSPR traded up $0.10 during trading on Friday, reaching $2.70. 96,553 shares of the company traded hands, compared to its average volume of 35,681. The stock has a market cap of $82.71 million, a P/E ratio of -3.60 and a beta of 0.74. The firm's fifty day simple moving average is $2.72 and its 200 day simple moving average is $2.74. InspireMD, Inc. has a 12-month low of $1.95 and a 12-month high of $3.80.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on InspireMD in a report on Sunday, April 27th. They set a "sell" rating for the company.

InspireMD Company Profile

InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.